Takeda Oncology
Justin Davino currently serves as the Oncology Territory Manager for CRC at Takeda Oncology, a position held since September 2023. Prior to this role, Justin worked at Bristol Myers Squibb as a Senior Hematology Consultant from April 2020 to August 2023. Justin's career in the pharmaceutical industry began at Eli Lilly and Company, where an Executive Specialty Sales Representative role was occupied from July 2006 to April 2020. Earlier professional experience includes serving as a Territory Manager at CAR Financial Services from October 2001 to June 2006. Justin Davino holds a Bachelor of Business Administration in Finance from Western Connecticut State University.
This person is not in any teams
This person is not in any offices
Takeda Oncology
20 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.